PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.

Jacot, William; Dalenc, Florence; Lopez-Crapez, Evelyne; Chaltiel, Leonor; Durigova, Anna; Gros, Nathalie; Lozano, Nicolas; Lacaze, Jean-Louis; Pouderoux, Stéphane; Gladieff, Laurence; Romieu, Gilles; Roché, Henri; Filleron, Thomas; Lamy, Pierre-Jean.
Breast Cancer Res Treat; 177(3): 659-667, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31297647

Não foram localizados documentos relacionados